- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Neutropenia Biologic Drug Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Neutropenia Biologic Drug Treatment size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Neutropenia Biologic Drug Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Neutropenia Biologic Drug Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim
Market segment by Application can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
The key market players for global Neutropenia Biologic Drug Treatment market are listed below:
Amgen
Novartis
Pfizer
Baxter International
Cellerant Therapeutics
Dong-A ST Co.,Ltd.
Myelo Therapeutics GmbH
Sanofi
Teva Pharmaceutical Industries Ltd.
Kyowa Kirin
CVS Health
Partner Therapeutics
Enzychem Lifesciences Corporation
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Neutropenia Biologic Drug Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neutropenia Biologic Drug Treatment, with price, sales, revenue and global market share of Neutropenia Biologic Drug Treatment in 2018 and 2019.
Chapter 3, the Neutropenia Biologic Drug Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neutropenia Biologic Drug Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Neutropenia Biologic Drug Treatment market forecast, by regions, drug type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Neutropenia Biologic Drug Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Neutropenia Biologic Drug Treatment Introduction
1.2 Market Analysis by Drug Type
1.2.1 Overview: Global Neutropenia Biologic Drug Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Filgrastim
1.2.3 Pegfilgrastim
1.2.4 Lenograstim
1.2.5 Lipegfilgrastim
1.2.6 Sargramostim
1.3 Market Analysis by Application
1.3.1 Overview: Global Neutropenia Biologic Drug Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Neutropenia Biologic Drug Treatment Market Size & Forecast
1.4.1 Global Neutropenia Biologic Drug Treatment Sales in Value (2016-2026))
1.4.2 Global Neutropenia Biologic Drug Treatment Sales in Volume (2016-2026)
1.4.3 Global Neutropenia Biologic Drug Treatment Price by Type (2016-2026) & (US$/Unit)
1.5 Global Neutropenia Biologic Drug Treatment Production Capacity Analysis
1.5.1 Global Neutropenia Biologic Drug Treatment Total Production Capacity (2016-2026)
1.5.2 Global Neutropenia Biologic Drug Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neutropenia Biologic Drug Treatment Market Drivers
1.6.2 Neutropenia Biologic Drug Treatment Market Restraints
1.6.3 Neutropenia Biologic Drug Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Neutropenia Biologic Drug Treatment Product and Services
2.1.4 Amgen Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Neutropenia Biologic Drug Treatment Product and Services
2.2.4 Novartis Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Neutropenia Biologic Drug Treatment Product and Services
2.3.4 Pfizer Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Baxter International
2.4.1 Baxter International Details
2.4.2 Baxter International Major Business
2.4.3 Baxter International Neutropenia Biologic Drug Treatment Product and Services
2.4.4 Baxter International Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Cellerant Therapeutics
2.5.1 Cellerant Therapeutics Details
2.5.2 Cellerant Therapeutics Major Business
2.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product and Services
2.5.4 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dong-A ST Co.,Ltd.
2.6.1 Dong-A ST Co.,Ltd. Details
2.6.2 Dong-A ST Co.,Ltd. Major Business
2.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product and Services
2.6.4 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Myelo Therapeutics GmbH
2.7.1 Myelo Therapeutics GmbH Details
2.7.2 Myelo Therapeutics GmbH Major Business
2.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product and Services
2.7.4 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Neutropenia Biologic Drug Treatment Product and Services
2.8.4 Sanofi Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business
2.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product and Services
2.9.4 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kyowa Kirin
2.10.1 Kyowa Kirin Details
2.10.2 Kyowa Kirin Major Business
2.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Product and Services
2.10.4 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 CVS Health
2.11.1 CVS Health Details
2.11.2 CVS Health Major Business
2.11.3 CVS Health Neutropenia Biologic Drug Treatment Product and Services
2.11.4 CVS Health Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Partner Therapeutics
2.12.1 Partner Therapeutics Details
2.12.2 Partner Therapeutics Major Business
2.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Product and Services
2.12.4 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Enzychem Lifesciences Corporation
2.13.1 Enzychem Lifesciences Corporation Details
2.13.2 Enzychem Lifesciences Corporation Major Business
2.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product and Services
2.13.4 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Neutropenia Biologic Drug Treatment Sales by Manufacturer
3.1 Global Neutropenia Biologic Drug Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neutropenia Biologic Drug Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neutropenia Biologic Drug Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Neutropenia Biologic Drug Treatment Manufacturer Market Share
3.4.2 Top 6 Neutropenia Biologic Drug Treatment Manufacturer Market Share
3.5 Global Neutropenia Biologic Drug Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neutropenia Biologic Drug Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neutropenia Biologic Drug Treatment Market Size by Region
4.1.1 Global Neutropenia Biologic Drug Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global Neutropenia Biologic Drug Treatment Revenue by Region (2016-2026)
4.2 North America Neutropenia Biologic Drug Treatment Revenue (2016-2026)
4.3 Europe Neutropenia Biologic Drug Treatment Revenue (2016-2026)
4.4 Asia-Pacific Neutropenia Biologic Drug Treatment Revenue (2016-2026)
4.5 South America Neutropenia Biologic Drug Treatment Revenue (2016-2026)
4.6 Middle East and Africa Neutropenia Biologic Drug Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neutropenia Biologic Drug Treatment Sales in Volume by Type (2016-2026)
5.2 Global Neutropenia Biologic Drug Treatment Revenue by Type (2016-2026)
5.3 Global Neutropenia Biologic Drug Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neutropenia Biologic Drug Treatment Sales in Volume by Application (2016-2026)
6.2 Global Neutropenia Biologic Drug Treatment Revenue by Application (2016-2026)
6.3 Global Neutropenia Biologic Drug Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neutropenia Biologic Drug Treatment Sales by Type (2016-2026)
7.2 North America Neutropenia Biologic Drug Treatment Sales by Application (2016-2026)
7.3 North America Neutropenia Biologic Drug Treatment Market Size by Country
7.3.1 North America Neutropenia Biologic Drug Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America Neutropenia Biologic Drug Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neutropenia Biologic Drug Treatment Sales by Type (2016-2026)
8.2 Europe Neutropenia Biologic Drug Treatment Sales by Application (2016-2026)
8.3 Europe Neutropenia Biologic Drug Treatment Market Size by Country
8.3.1 Europe Neutropenia Biologic Drug Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe Neutropenia Biologic Drug Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region
9.3.1 Asia-Pacific Neutropenia Biologic Drug Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neutropenia Biologic Drug Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neutropenia Biologic Drug Treatment Sales by Type (2016-2026)
10.2 South America Neutropenia Biologic Drug Treatment Sales by Application (2016-2026)
10.3 South America Neutropenia Biologic Drug Treatment Market Size by Country
10.3.1 South America Neutropenia Biologic Drug Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America Neutropenia Biologic Drug Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country
11.3.1 Middle East & Africa Neutropenia Biologic Drug Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neutropenia Biologic Drug Treatment Typical Distributors
12.3 Neutropenia Biologic Drug Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Neutropenia Biologic Drug Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neutropenia Biologic Drug Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Neutropenia Biologic Drug Treatment Product and Services
Table 6. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Neutropenia Biologic Drug Treatment Product and Services
Table 10. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Neutropenia Biologic Drug Treatment Product and Services
Table 14. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Baxter International Basic Information, Manufacturing Base and Competitors
Table 16. Baxter International Major Business
Table 17. Baxter International Neutropenia Biologic Drug Treatment Product and Services
Table 18. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cellerant Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Cellerant Therapeutics Major Business
Table 21. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product and Services
Table 22. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dong-A ST Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Dong-A ST Co.,Ltd. Major Business
Table 25. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product and Services
Table 26. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Myelo Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 28. Myelo Therapeutics GmbH Major Business
Table 29. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product and Services
Table 30. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Neutropenia Biologic Drug Treatment Product and Services
Table 34. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharmaceutical Industries Ltd. Major Business
Table 37. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product and Services
Table 38. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 40. Kyowa Kirin Major Business
Table 41. Kyowa Kirin Neutropenia Biologic Drug Treatment Product and Services
Table 42. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. CVS Health Basic Information, Manufacturing Base and Competitors
Table 44. CVS Health Major Business
Table 45. CVS Health Neutropenia Biologic Drug Treatment Product and Services
Table 46. CVS Health Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Partner Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Partner Therapeutics Major Business
Table 49. Partner Therapeutics Neutropenia Biologic Drug Treatment Product and Services
Table 50. Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Enzychem Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table 52. Enzychem Lifesciences Corporation Major Business
Table 53. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product and Services
Table 54. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Neutropenia Biologic Drug Treatment Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Neutropenia Biologic Drug Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Neutropenia Biologic Drug Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Neutropenia Biologic Drug Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Neutropenia Biologic Drug Treatment Production Site of Key Manufacturer
Table 60. Neutropenia Biologic Drug Treatment New Entrant and Capacity Expansion Plans
Table 61. Neutropenia Biologic Drug Treatment Mergers & Acquisitions in the Past Five Years
Table 62. Global Neutropenia Biologic Drug Treatment Sales by Region (2016-2021e) & (K Units)
Table 63. Global Neutropenia Biologic Drug Treatment Sales by Region (2021-2026) & (K Units)
Table 64. Global Neutropenia Biologic Drug Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Neutropenia Biologic Drug Treatment Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 67. Global Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 68. Global Neutropenia Biologic Drug Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Neutropenia Biologic Drug Treatment Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Neutropenia Biologic Drug Treatment Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Neutropenia Biologic Drug Treatment Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 73. Global Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 74. Global Neutropenia Biologic Drug Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Neutropenia Biologic Drug Treatment Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Neutropenia Biologic Drug Treatment Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Neutropenia Biologic Drug Treatment Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Neutropenia Biologic Drug Treatment Sales by Country (2016-2021e) & (K Units)
Table 79. North America Neutropenia Biologic Drug Treatment Sales by Country (2021-2026) & (K Units)
Table 80. North America Neutropenia Biologic Drug Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Neutropenia Biologic Drug Treatment Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 83. North America Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 84. North America Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 85. North America Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 86. Europe Neutropenia Biologic Drug Treatment Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Neutropenia Biologic Drug Treatment Sales by Country (2021-2026) & (K Units)
Table 88. Europe Neutropenia Biologic Drug Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Neutropenia Biologic Drug Treatment Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 92. Europe Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Neutropenia Biologic Drug Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Neutropenia Biologic Drug Treatment Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 102. South America Neutropenia Biologic Drug Treatment Sales by Country (2016-2021e) & (K Units)
Table 103. South America Neutropenia Biologic Drug Treatment Sales by Country (2021-2026) & (K Units)
Table 104. South America Neutropenia Biologic Drug Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Neutropenia Biologic Drug Treatment Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 107. South America Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 108. South America Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 109. South America Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Neutropenia Biologic Drug Treatment Typical Distributors
Table 121. Neutropenia Biologic Drug Treatment Typical Customers
List of Figures
Figure 1. Neutropenia Biologic Drug Treatment Picture
Figure 2. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type in 2020
Figure 3. Filgrastim
Figure 4. Pegfilgrastim
Figure 5. Lenograstim
Figure 6. Lipegfilgrastim
Figure 7. Sargramostim
Figure 8. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application in 2020
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Neutropenia Biologic Drug Treatment Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Neutropenia Biologic Drug Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Neutropenia Biologic Drug Treatment Sales (2016-2026) & (K Units)
Figure 15. Global Neutropenia Biologic Drug Treatment Price by Type (2016-2026) & (US$/Unit)
Figure 16. Global Neutropenia Biologic Drug Treatment Production Capacity (2016-2026) & (K Units)
Figure 17. Global Neutropenia Biologic Drug Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Neutropenia Biologic Drug Treatment Market Drivers
Figure 19. Neutropenia Biologic Drug Treatment Market Restraints
Figure 20. Neutropenia Biologic Drug Treatment Market Trends
Figure 21. Global Neutropenia Biologic Drug Treatment Sales Market Share by Manufacturer in 2020
Figure 22. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Manufacturer in 2020
Figure 23. Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Neutropenia Biologic Drug Treatment Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Neutropenia Biologic Drug Treatment Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2016-2026)
Figure 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2016-2026)
Figure 28. North America Neutropenia Biologic Drug Treatment Revenue (2016-2026) & (USD Million)
Figure 29. Europe Neutropenia Biologic Drug Treatment Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Neutropenia Biologic Drug Treatment Revenue (2016-2026) & (USD Million)
Figure 31. South America Neutropenia Biologic Drug Treatment Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue (2016-2026) & (USD Million)
Figure 33. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2016-2026)
Figure 34. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2016-2026)
Figure 35. Global Neutropenia Biologic Drug Treatment Price by Type (2016-2026) & (US$/Unit)
Figure 36. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 37. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2016-2026)
Figure 38. Global Neutropenia Biologic Drug Treatment Price by Application (2016-2026) & (US$/Unit)
Figure 39. North America Neutropenia Biologic Drug Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Neutropenia Biologic Drug Treatment Sales Market Share by Country (2016-2026)
Figure 42. North America Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2016-2026)
Figure 43. United States Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Type (2016-2026)
Figure 47. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 48. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country (2016-2026)
Figure 49. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2016-2026)
Figure 50. Germany Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Neutropenia Biologic Drug Treatment Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Neutropenia Biologic Drug Treatment Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2016-2026)
Figure 59. China Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Neutropenia Biologic Drug Treatment Sales Market Share by Type (2016-2026)
Figure 66. South America Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America Neutropenia Biologic Drug Treatment Sales Market Share by Country (2016-2026)
Figure 68. South America Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Neutropenia Biologic Drug Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
